Abbott Laboratories CEO Miles White said Thursday in an earnings call that he was "quite confident" the company will complete its $5.3 billion acquisition of Alere this year and that Abbott is expected to announce a related asset sale. The company reported that its medical devices business saw an increase of about 89% in sales during the second quarter, generating $2.6 billion on a reported basis.
Abbott CEO bullish on Alere purchase completion this year
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.